DIVISLAB's weekly performance was disappointing, with a return of -5.26% and a max drawdown of the same magnitude, indicating a significant decline in value. The stock's volatility was high at 32.17%, making it a risky investment this week. Compared to its peers, DIVISLAB underperformed, with a lower return and higher volatility than DRREDDY and CIPLA, and significantly lower than SUNPHARMA. Overall, the stock's poor performance and high risk make it an unattractive option for investors.

[Volatility: 32.17%]